Evidence map›Paper›PMID 34298585›Full record

ReviewHuman mutation2021

SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.

Matthew M Heeney, Simon Berhe, Dean R Campagna, Joseph H Oved, Peter Kurre, Peter J Shaw, Juliana Teo, Mayada A Shanap, Hoda M Hassab, Bertil E Glader and 17 more

Open access · goldAbstract readReview
In one paragraph

Review in Human mutation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. From the cytosol to the inner membrane: biogenesis of the mitochondrial carrier family.Protein science : a publication of the Protein Society · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A novel and apparentFrontiers in pediatrics · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. New Avenues of Heme Synthesis Regulation.International journal of molecular sciences · 2022
    Review
  17. Regulation of Heme Synthesis by Mitochondrial Homeostasis Proteins.Frontiers in cell and developmental biology · 2022
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 8 countries.

Matthew M HeeneyDivision of Hematology, Dana-Farber Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Simon BerheDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Dean R CampagnaDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Joseph H OvedCellular Therapy and Transplant Section, Division of Oncology and Comprehensive Bone Marrow Failure Center, Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia, USA.
Peter KurrePediatric Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Peter J ShawBMT Services, Children's Hospital at Westmead; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Juliana TeoDepartment of Haematology, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Mayada A ShanapKing Hussein Medical Center, Amman, Jordan.
Hoda M HassabDepartment of Paediatrics, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Bertil E GladerDivision of Hematology-Oncology, Lucille Packard Children's Hospital, Stanford, California, USA.
Sanjay ShahCenter for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Ayami YoshimiDepartment of Paediatrics and Adolescent Medicine, Division of Paediatric Haematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Afshin AmeriDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Augusta University, Augusta, Georgia, USA.
Joseph H AntinHematopoietic Stem Cell Transplantation Program, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.
Jeanne BoudreauxAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.
Michael BrionesAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.
Kathryn E DickersonDepartment of Pediatrics, University of Texas Southwestern, Dallas, Texas, USA.
Conrad V FernandezDivision of Hematology-Oncology, IWH Center, Dalhousie University, Halifax, Nova Scotia, Canada.
Roula FarahDepartment of Pediatrics, Lebanese American University Medical Center, Beirut, Lebanon.
Henrik HasleDepartment of Pediatrics, Aarhus University Hospital, Aarhus University, Aarhus, Denmark.
Sioban B KeelDivision of Hematology, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington, USA.
Timothy S OlsonCellular Therapy and Transplant Section, Division of Oncology and Comprehensive Bone Marrow Failure Center, Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Jacquelyn M PowersTexas Children's Hospital and Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.
Melissa J RoseDivision of Hematology & Oncology, Nationwide Children's Hospital, Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA.
Akiko ShimamuraDivision of Hematology, Dana-Farber Boston Children's Cancer and Blood Disorders Center and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Sylvia S BottomleyHematology-Oncology Section, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA.
Mark D FlemingDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-0948-4024
Boston Children's Hospital · USChildren's Hospital of Philadelphia · USHarvard University · USEmory University · USAarhus University Hospital · DKAlexandria University · EGAmerican University of Beirut Medical Center · LBAugusta University · USBaylor College of Medicine · USCenter for Cancer and Blood Disorders · USChildren's Hospital at Westmead · AUDalhousie University · CAKing Hussein Medical Center · JOLucile Packard Children's Hospital · USNationwide Children's Hospital · USOklahoma City University · USSeattle Cancer Care Alliance · USThe University of Sydney · AUThe University of Texas Southwestern Medical Center · USUniversity of Freiburg · DE

Funding

Systems Biology of Bone Marrow Failure and MDS for Precision MedicineRC2DK122533 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FIGUEROA, MARIA EUGENIA, FLEMING, MARK D · 2019 to 2023
$6.4M
Molecular Genetics of Sideroblastic AnemiaR01DK087992 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FLEMING, MARK D · 2011 to 2015
$2.0M
NIDDK NIH HHS R01 DK087992NIDDK NIH HHS RC2 DK122533
6 · The paper itself

Abstract

The congenital sideroblastic anemias (CSAs) are a heterogeneous group of inherited disorders of erythropoiesis characterized by pathologic deposits of iron in the mitochondria of developing erythroblasts. Mutations in the mitochondrial glycine carrier SLC25A38 cause the most common recessive form of CSA. Nonetheless, the disease is still rare, there being fewer than 70 reported families. Here we describe the clinical phenotype and genotypes of 31 individuals from 24 families, including 11 novel mutations. We also review the spectrum of reported mutations and genotypes associated with the disease, describe the unique localization of missense mutations in transmembrane domains and account for the presence of several alleles in different populations.

Indexed as

GenotypeMutationPhenotypeAnemia, SideroblasticChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMitochondrial Membrane Transport ProteinsMitochondrial Membrane Transport ProteinsSlc25a38 protein, humanerythropoiesisgeneticshematopoietic stem cell transplantationironsideroblastic anemia

Identifiers

PMID34298585
PMCPMC8511274
OpenAlexW3131585130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.